Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614029 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
A Phase 1 study, sponsored by Zogenix.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT00614029: Completed Phase 1 study, sponsored by Zogenix.
NCT00614029 is a Phase 1 study that has completed, run by Zogenix. The registered enrollment target is 54 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00614029, a Phase 1 study, has completed, sponsored by Zogenix.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
A study to evaluate the pharmacokinetics and bioequivalence of sumatriptan delivered by the Intraject system.
Interventions
- DEVICE Sumatriptan (via Intraject System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-12 |
| Phase | Phase 1 |
What the finished NCT00614029 record still lists
NCT00614029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Sumatriptan (via Intraject System) is the first listed.
NCT00614029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00614029 about?
NCT00614029 is a clinical study titled "A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System". A study to evaluate the pharmacokinetics and bioequivalence of sumatriptan delivered by the Intraject system.
What is the current status of trial NCT00614029?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2006-12.
What interventions are being tested in trial NCT00614029?
The interventions under investigation include: Sumatriptan (via Intraject System) (DEVICE).
Who is sponsoring clinical trial NCT00614029?
This trial is sponsored by Zogenix, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00614029's enrollment target sits among peer trials
54 931st of 2000 higher than 1,053 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia